Summary Epidemiological studies of active smokers have shown that the duration of smoking has a much greater effect on lung cancer risk than the amount smoked. This observation suggests that passive smoking might be much more harmful than would be predicted from measures of the level of exposure alone, as it is often of very long duration frequently beginning in early childhood. In this paper we have investigated this using a multistage model with five stages. The model is shown to provide an excellent fit to data on the incidence of lung cancer among smokers, ex-smokers and non-smokers in a cohort of male British doctors. Contrary to our expectation the model predicted only a slight increase in relative risk with increasing duration of passive exposure. Allowing for exposures early in life does not therefore explain the discrepancy between the relative risk of about 1.5 calculated from epidemiological studies of lung cancer and the low levels of exposure indicated by cotinine measurements in those passively exposed.
It has been suggested, using data from epidemiological studies of lung cancer and passive smoking (i.e. exposure to other people's tobacco smoke), that the relative risk of lung cancer among non-smokers living with smokers, compared to non-smokers living with non-smokers is about 1.5 (see, for example, Wald et al., 1986) . This estimate of relative risk is considerably higher than one would predict on the basis of studies of cotinine levels in non-smokers living with smokers (Committee on Passive Smoking, 1986) . It is clear that epidemiological studies of passive smoking are particularly difficult to carry out because of the large errors inherent in obtaining adequate histories of such past exposure and because the studies need to avoid even slight biases as the relative risks involved are small.
Epidemiological studies of active smokers have however shown that the duration of smoking has a much greater effect on lung cancer risk than the amount smoked. For example heavy smokers (30 cigarettes per day) of 15 years duration have been shown to have only about one tenth the excess lung cancer risk of moderate smokers (15 cigarettes per day) who have smoked for 30 years, although the total number of cigarettes smoked is the same (Peto & Doll, 1984) . This observation suggests that exposure to tobacco smoke at the low levels incurred during passive smoking might be much more harmful than would be predicted from measures of the level of the exposure alone, as passive exposure is often of very long duration frequently beginning in early childhood.
In this paper we have investigated the possible effects of such long duration exposure to passive smoking starting in childhood by modelling the effect of cigarette smoke on lung cancer incidence using a multistage model, and compared the estimates so obtained to those observed in epidemiological studies.
A multistage model for lung cancer
The model The idea that a cancer is generated only after a cell has undergone a series of distinct, ordered, transformations or 'stages' was introduced to explain the observation that the mortality rates for many sites of cancer that are epithelial in origin increase as the fourth, fifth, or sixth power of age.
Multistage models have also been highly successful in describing many features of experimental carcinogenesis, for a review see Peto (1977) or Day (1983) . The model as proposed originally by Armitage & Doll (1961) is the best known formulation and a brief description of it is given in the Appendix. In this formulation, if there are k stages involved for the cancer in question (normal cell=stage 'O', stage 1,.. ., stage k=cancer cell), we denote the probability that a cell which is at stage i-I transforms into stage i in unit time as a ai, i=l,...,k. According to this model, if these ai remain constant throughout life, and if the time for a fully transformed malignant cell to grow into a clinically detectable tumour is ignored, then the incidence rate at age t will be proportional to tk-'. It follows that if the logarithm of the age-specific incidence rates are plotted against the logarithm of age, then the plotted points will fall on a straight line with slope k-1.
Data on the incidence of lung cancer in non-smoking US males have been published by Kahn (1966) and Hammond (1966) , and together include 127 cases of lung cancer. The data have been combined by Doll (1971) and are reproduced in Figure 1 . It can be seen that they lie very close to a straight line with slope four, indicating that five stages are appropriate in the model for lung cancer. Among regular cigarette smokers the incidence rises more rapidly with age, and the slope of the line is about seven, but when the rates are plotted against duration of smoking, rather than age, the incidence again rises approximately as the fourth power, see Figure 1 (Doll, 1971) .
In order to understand which stages in the multistage model are affected by smoking, it is necessary to consider the following two critical epidemiological observations. Firstly the fact that age at starting to smoke and duration of smoking are critical determinants of lung cancer risk, and secondly the fact that after stopping smoking the incidence rate remains approximately at the level when smoking stopped (Doll & Peto, 1976) . In terms of the multistage model, these can be shown to imply that cigarette smoke has a strong effect on an early stage, probably the first, and also that it affects a late stage, but not the last (Doll, 1978; Day & Brown, 1980) . When attention is restricted to smokers of cigarettes only, who also have a record of unchanging smoking habits, the relation between lung cancer incidence and number of cigarettes smoked per day is greater than linear, see Figure 2 , and this provides additional evidence that more than one stage in the process is affected (Doll & Peto, 1978) .
In the present paper we first show that a multistage model Doll & Peto (1978) . In the data all the doctors had started smoking when they were between 16 and 25 years old. In estimating b, and b4 it was assumed for simplicity that all the smokers had started smoking at 20 years of age. This method of fitting enables the effect of cigarette smoking to be estimated in terms of relative risks. To make predictions in terms of absolute incidence rates we have assumed in what follows that the incidence rate in non-smokers at age 60 is equal to that observed in the data on non-smokers in Figure 1 .
The estimated values for b, and b4 are 0.29 and 0.37 with estimated standard errors of 0.32 and 0.35. The fit of the model to the British doctors' data is excellent. Pearson's goodness-of-fit statistic is 52.4 and the residual deviance is 51.1; both of these statistics have 54 degrees of freedom and thus provide no evidence of a poor fit to the data. A plot of standardized residuals against normal order statistics indicated that the model fitted the data well, and plots of residuals against both current age and number of cigarettes smoked per day gave no evidence of systematic departures from the model. The ability of the model to reproduce the main features of cigarette smoking, as observed in the British doctors' study, is illustrated in Figures 2 to 4. In Figure 2 it can be seen that the dose response relationship from the multistage model reproduces very closely the approximately quadratic relationship observed in the data. Figure 3 shows Figure 4a shows data on the risk of lung cancer among British doctors who stopped smoking, by time since stopping, relative to their risk at the time they stopped. For comparison, risks are shown on the same scale for continuing cigarette smokers and lifelong non-smokers. The beneficial effect of stopping smoking is evident within five years, and there is a possibility that the incidence rate may actually decrease during the first 10 years after stopping smoking. However, the data are too few to be certain that this is so, and it is clear that the risk keeps well above that for lifelong non-smokers (Doll, 1978) . The equation predicting the effect of giving up smoking according to the multistage model is given in the Appendix, and it is illustrated in Figure 4b , where it is assumed that the smokers Risk relative to that expected at rates for cigarette smokers at age ex-smokers stopped Figure 4 Comparison of the effect of stopping smoking observed in British doctors' study with that obtained from the proposed multistage model. Risk is measured relative to the risk in a regular cigarette smoker at the ages at which smoking was stopped (a) Data from British doctors' study, amd US nonsmokers standardized for amount smoked at time of stopping.
(Data from Doll. 1978, chart _ 1 -j 0 few years after stopping, and using the equation for the relative risk in an ex-smoker shown in the Appendix it can be shown that under the proposed model the incidence of lung cancer will never decrease below that already reached at the time of stopping smoking regardless of amount smoked or ages at starting and stopping. There is evidence from pathological studies of tracheo-bronchial trees that the number of atypical nuclei in the bronchial epithelium diminishes on cessation of smoking (Auerbach et al., 1962) , and this observation lends some support to the idea that the risk of lung cancer might actually decrease in the first few years after giving up smoking. However, the slight discrepancy between the observations on British doctors and the predictions from the model could also be accounted for by random variation, or by the fact that individuals who succeed in giving up smoking were less likely to inhale than continuing smokers (Doll & Hill, 1964 (Lee, 1976 In terms of the mathematical formulation of the model given in the Appendix, it is clear from the expression for IC(s, t), the incidence rate at age t in the smoker of c cigarettes per day since age s, that as c increases the term involving c2b1b4, which involves duration to the fourth power, will begin to dominate. For small values of c (i.e. less than bj 1 and b4 1) it can easily be shown that the term involving cb4, which increases only very slowly with duration, will play the major role in determining the incidence rate for values of b1, b4, s and t that are of concern here. In non-mathematical terms this amounts to the fact that, for active smokers of a substantial number of cigarettes, the incidence rate of lung cancer is determined by the effect of smoking on both the first and the fourth stages. In contrast, at levels equal to the numbers of cigarettes effectively smoked by passive smokers, the effect of those cigarettes is primarily on the fourth stage, and its effect on the first stage is relatively minor. Wald et al. (1986) The biological marker that has proved most useful in assessing average daily exposure to tobacco smoke among those exposed to passive smoking is cotinine (Committee on Passive Smoking, 1986) . Recent studies in the UK measuring cotinine levels in active and passive smokers in plasma, urine and saliva indicate that levels in passive smokers are in the range 0.6 to 0.8% of those in active smokers (Jarvis et al., 1984) . However the half-life of cotinine in non-smokers may be roughly 50% longer than in active smokers (Sepkovic et al., 1986) . Active smokers in the UK currently smoke between 15 and 20 cigarettes per day (Wald et al., 1988) and so the cotinine measurements indicate an exposure of between 0.06 and 0.11 cigarettes per day. According to the proposed multistage model, a relative risk of 1.5, as estimated by Wald et al. (1986) from the epidemiological studies of exposure to passive smoking, results from the effective exposure to about half to one cigarette per day. Thus the cotinine measurements indicate a level of exposure that is between one seventeenth and one fifth the amount indicated by our model. This estimate is based on cigarettes available during the 1950s and 1960s and used by the men in the British doctors' study: to the extent that currently available cigarettes are associated with lower lung cancer risks these factors would be somewhat reduced. A further difficulty is that the relationship between the amount of nicotine absorbed, and the amount of tar deposited on the bronchi is not necessarily the same in passive as in active smoking, and this could influence the postulated risk in either direction. We conclude, however, that the relative risks of lung cancer due to passive smoking as estimated by Wald et al. (1986) seem to be at variance with the numbers of cigarettes per day equivalent estimated from cotinine measurements. This discrepancy remains even when allowance is made, within the framework of our model, for the fact that passive smoking may commence in early childhood, and when the parameters of the model are estimated allowing the British doctors' themselves to have been exposed to passive smoking.
